CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
High ImpactOriginal article

Curium Announces Definitive Agreement to Merge with Lantheus

Positive
AI Analysis

Summary

Curium and Lantheus announced a definitive agreement to merge in an $8 billion transaction, creating a global radiopharmaceutical leader with operations across oncology, neurology, and cardiology in over 70 countries.

Importance:8/10
Sentiment:
0.70
M&Aradiopharmaceuticaloncologyneurologycardiologymergerdefinitive agreement
Related Companies

Read the original article

Published by GlobeNewswire Pharma on August 3, 2026 11:38 AM

Read Original